Antibody Response to Breakthrough SARS-CoV-2 Infection in "Booster" Vaccinated Patients with Multiple Myeloma According to B/T/NK Lymphocyte Absolute Counts and anti-CD38 Treatments.

Sgherza, Nicola; Mestice, Anna; Larocca, Angela Maria Vittoria; Musto, Pellegrino

Sgherza, Nicola; Mestice, Anna; Larocca, Angela Maria Vittoria; Musto, Pellegrino.

Afiliación

Sgherza N; Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.
Mestice A; Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.
Larocca AMV; Hygiene Unit, AOUC Policlinico, Bari, Italy.
Musto P; Hematology and Stem Cell Transplantation Unit, AOUC Policlinico, Bari, Italy.

Mediterr J Hematol Infect Dis ; 16(1): e2024022, 2024.

Article en En | MEDLINE | ID: mdl-38468827

Palabras clave

Breakthrough SARS-CoV-2 infection; Multiple myeloma; Serological response

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mediterr J Hematol Infect Dis Año: 2024 Tipo del documento: Article País de afiliación: Italia Pais de publicación: Italia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google